BridgeBio Oncology Therapeutics, Inc.

Market Cap

$685M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$7.81-$4.48 (-36.45%)

Jun 5, 2026

52W High $13.7352W Low $7.66

Company Details

BridgeBio Oncology Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of small-molecule therapeutics for the treatment of renin-angiotensin system and phosphoinositide 3-kinase malignancies in the United ...

CEO

—

IPO Date

Aug 12, 2025

Website

bbotx.com

Key Metrics TTM

Revenue

- YoY

Net Income

-$154M

EPS (Diluted)

Free Cash Flow

-$173M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q2 2026

Aug 11, 2026

PENDING

Q1 2026

May 12, 2026

FY 2025

Mar 5, 2026

Q4 2025

Mar 5, 2026

Q3 2025

Nov 12, 2025

Revenue & Profitability

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee